FI105815B - Spikamysiinijohdannaisten valmistusmenetelmä ja siinä käytettävät välituotteet - Google Patents

Spikamysiinijohdannaisten valmistusmenetelmä ja siinä käytettävät välituotteet Download PDF

Info

Publication number
FI105815B
FI105815B FI923170A FI923170A FI105815B FI 105815 B FI105815 B FI 105815B FI 923170 A FI923170 A FI 923170A FI 923170 A FI923170 A FI 923170A FI 105815 B FI105815 B FI 105815B
Authority
FI
Finland
Prior art keywords
purine
spicaminylamino
acid
mixture
added
Prior art date
Application number
FI923170A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI923170A0 (fi
FI923170A (fi
Inventor
Noboru Otake
Hiroyuki Kawai
Tomiko Kawasaki
Atsuo Odagawa
Masaru Kamishohara
Teruyuki Sakai
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Publication of FI923170A0 publication Critical patent/FI923170A0/fi
Publication of FI923170A publication Critical patent/FI923170A/fi
Application granted granted Critical
Publication of FI105815B publication Critical patent/FI105815B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI923170A 1991-07-12 1992-07-09 Spikamysiinijohdannaisten valmistusmenetelmä ja siinä käytettävät välituotteet FI105815B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP19890391 1991-07-12
JP19890391 1991-07-12
JP32684591 1991-11-15
JP32684591 1991-11-15
JP11066592 1992-04-03
JP4110665A JP2783722B2 (ja) 1991-07-12 1992-04-03 スピカマイシン誘導体およびそれを含む抗腫瘍剤

Publications (3)

Publication Number Publication Date
FI923170A0 FI923170A0 (fi) 1992-07-09
FI923170A FI923170A (fi) 1993-01-13
FI105815B true FI105815B (fi) 2000-10-13

Family

ID=27311786

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923170A FI105815B (fi) 1991-07-12 1992-07-09 Spikamysiinijohdannaisten valmistusmenetelmä ja siinä käytettävät välituotteet

Country Status (16)

Country Link
US (2) US5461036A (de)
EP (1) EP0525479B1 (de)
JP (1) JP2783722B2 (de)
KR (1) KR100253050B1 (de)
AT (1) ATE159948T1 (de)
AU (1) AU657551B2 (de)
CA (1) CA2073567C (de)
DE (1) DE69222992T2 (de)
DK (1) DK0525479T3 (de)
ES (1) ES2111019T3 (de)
FI (1) FI105815B (de)
GR (1) GR3025293T3 (de)
HK (1) HK1001729A1 (de)
HU (1) HU221808B1 (de)
NO (1) NO178500C (de)
SG (1) SG52704A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7017208B2 (en) * 1995-08-04 2006-03-28 Hill-Rom Services, Inc. Hospital bed
US5905069A (en) * 1998-01-26 1999-05-18 The General Hospital Corporation Methods of decreasing or preventing pain using spicamycin or derivatives thereof
DE60006216T2 (de) * 1999-01-22 2004-07-15 Kirin Beer K.K. Chinolinderivate und chinazolinderivate
AU2001291133A1 (en) * 2000-09-20 2002-04-02 The General Hospital Corporation Methods of decreasing or preventing pain using spicamycin derivatives
WO2004045637A1 (en) * 2002-11-18 2004-06-03 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
CN1878748B (zh) * 2003-09-11 2010-04-21 因维斯塔技术有限公司 氢氰化不饱和羧酸衍生物的方法
JP4608651B2 (ja) * 2004-06-24 2011-01-12 財団法人ヒューマンサイエンス振興財団 抗ガン作用を有する化合物、その製造方法及び抗ガン剤
US8119829B2 (en) * 2004-09-08 2012-02-21 Invista North America S.A.R.L. Process of hydrocyanation of unsaturated carboxylic acid derivatives
CN102202672A (zh) * 2008-10-10 2011-09-28 达拉生物科学公司 使用穗霉素衍生物治疗或预防疼痛的方法
EP2597082A1 (de) 2011-11-24 2013-05-29 Symrise AG Verbindungen zur Maskierung eines unangenehmen Geschmacks
KR20150038572A (ko) 2012-08-09 2015-04-08 다라 바이오싸이언시즈, 아이엔씨. 스피카마이신 유도체를 포함하는 조성물 및 이의 사용 방법
WO2015061481A1 (en) 2013-10-23 2015-04-30 Dara Biosciences, Inc. Methods of treating liquid tumors using compositions comprising spicamycin derivatives
CN110386874B (zh) * 2018-04-16 2022-10-04 湖北金鹤化工有限公司 一种12-酮基硬脂酸酯及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3264195A (en) * 1963-07-24 1966-08-02 Squibb & Sons Inc Process for the preparation of septacidin and derivatives
US3155647A (en) 1963-07-24 1964-11-03 Olin Mathieson Septaciding and derivatives thereof
US4086416A (en) * 1977-05-17 1978-04-25 Stanford Research Institute Septacidin analogs
JPS59161389A (ja) * 1983-03-07 1984-09-12 Eisai Co Ltd ７−カルボキシメトキシフエニルアセトアミドセフエム誘導体，その製造法およびそれからなる抗菌剤
JPS59161396A (ja) * 1983-03-04 1984-09-12 Kirin Brewery Co Ltd 新規抗生物質スピカマイシン
US4975434A (en) * 1986-05-27 1990-12-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antiviral and anticancer cyclopentenyl cytosine
WO1990015811A1 (en) 1989-06-16 1990-12-27 Kirin Beer Kabushiki Kaisha Spicamycin x and its use

Also Published As

Publication number Publication date
US5631238A (en) 1997-05-20
AU1960092A (en) 1993-01-14
HU9202285D0 (en) 1992-10-28
FI923170A0 (fi) 1992-07-09
FI923170A (fi) 1993-01-13
HUT61773A (en) 1993-03-01
GR3025293T3 (en) 1998-02-27
EP0525479B1 (de) 1997-11-05
ATE159948T1 (de) 1997-11-15
HU221808B1 (hu) 2003-01-28
NO922674D0 (no) 1992-07-08
DE69222992T2 (de) 1998-03-05
SG52704A1 (en) 1998-09-28
CA2073567C (en) 1998-05-05
KR100253050B1 (ko) 2000-04-15
JPH05186494A (ja) 1993-07-27
NO178500B (no) 1996-01-02
NO178500C (no) 1996-04-10
NO922674L (no) 1993-01-13
DE69222992D1 (de) 1997-12-11
DK0525479T3 (da) 1998-04-20
KR930002370A (ko) 1993-02-23
US5461036A (en) 1995-10-24
JP2783722B2 (ja) 1998-08-06
ES2111019T3 (es) 1998-03-01
HK1001729A1 (en) 1998-07-03
CA2073567A1 (en) 1993-01-13
EP0525479A1 (de) 1993-02-03
AU657551B2 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
KR100483256B1 (ko) 젬시타빈 유도체
FI105815B (fi) Spikamysiinijohdannaisten valmistusmenetelmä ja siinä käytettävät välituotteet
US4658058A (en) 11-O-methylspergualin
EP0354583A1 (de) DC-88A-Derivate
US4831038A (en) Vinblastine derivatives and pharmaceutical composition containing them
CA1335892C (en) Saccharide derivatives
US5696154A (en) Brefeldin A derivatives and their utility in the treatment of cancer
EP0393923A1 (de) 6-Fluorshikiminsäurederivate
EP0588317A1 (de) Uridinderivat und Verfahren zur Herstellung
US4362866A (en) Aprosamine derivatives
US4087603A (en) Antifungal antibiotics
EP3634974B1 (de) Tunicamycin-analoga
KR920002143B1 (ko) 5-치환 우리딘 유도체 및 그의 제조 중간체
EP0416605A1 (de) Oxetanocinderivate, ihre Salze und ihre Verwendung
GB2321454A (en) Gemcitabine esters and amides
WO1991004268A1 (en) [N-(η-GLUTAMYL)GLYCYL]ALANINE DERIVATIVES
TAKAMURA et al. Syntheses and antitumor activities of N6, N6-dimethyladenosine carboxylate analogues
WO1994012512A1 (en) Glucosylglucoside derivative
JPH0873489A (ja) スピカマイシン誘導体およびそれを含む抗腫瘍剤
JPH05208979A (ja) Ｄｃ１１３誘導体

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: KIRIN PHARMA KABUSHIKI KAISHA

Free format text: KIRIN PHARMA KABUSHIKI KAISHA

PC Transfer of assignment of patent

Owner name: KYOWA HAKKO KIRIN CO., LTD.

Free format text: KYOWA HAKKO KIRIN CO., LTD.